5Deitcher SR, FesenMR, Kiproff PM, et al. Safety and efficacy of alteplase for restoring function in occluded central venous catheterst results of the cardiovascular thrombolytic to open occluded lines trial. J Clin Oncol,2002, 20: 317-324.
6Jacobs BR, Haygood M, Hingl J. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr, 2001, 139: 593-596.
7Svoboda P, Barton RP, Barbarash OL, et al. Recombinant urokinase is ssfe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial. Crit Csre Med, 2004, 32:1990-1996.
8Horne MK 3rd, Thrombolytics for occluded catheters, Crit Care Med,2004, 32: 2146-2147.
9Hurtubise MR, Bottino JC, Lawson M, et al. Restoring patency of occluded central venous catheters, Arch Surg, 1980, 115:212-213.
10James L, Bledsoe L, Hadaway LC. A retrospective look at tip location and complications of peripherally inserted cen tral catheter lines[J]. J Intraven Nurs, 1993, 16(2):104-105
6Riccardo E,Vandoni,Adriano Guerra,et al.Randomised comparion of complications from three different permanent central venous access systems[J].Swiss Med Wkly,2009, 139(21):313- 316.
